evidence: With the World Health Organization this week declaring the mpox outbreak a global health emergency, Bavarian Nordic now faces a promising windfall opportunity for its smallpox vaccine Jynneos. [...] There are two known clades of mpox. In 2022, the milder clade II caused an outbreak in the U.S., forcing several states to declare local health emergencies. However, the current outbreak is caused by clade Ib, which according to WHO is a new virus strain that appears to be deadlier. Earlier this week, Africa CDC put out a call for support to mobilize two million mpox vaccines. [...] Jefferies analyst Peter Welford in a note to investors said the mpox emergency could be a "windfall" for Bavarian Nordic, which has said that it could produce around three million Jynneos doses this year, given that there are firm orders in place. The company can also make 10 million more doses available next year.